Back to search results

BPCARE: Improving Blood Pressure Care for Refugees

This study, called BPCARE, is testing an intervention to help adult refugees with high blood pressure (hypertension) better manage their medication. You might be able to join if you are at least 21 years old, have been diagnosed with high blood pressure, and speak English as a second language. Participants will receive a culturally appropriate education booklet, a pill organizer, and two sessions focused on taking medication correctly. The study wants to see if this BPCARE intervention improves how consistently people take their blood pressure medicine and if it helps control their blood pressure better over six months. The study is currently unclear on its recruitment status and plans to enroll 250 people.

Study design
This is an interventional, randomized study that plans to enroll 250 participants. It compares the BPCARE intervention to usual care.
What's involved
You would complete screening and baseline assessments, then be followed for a total of six months. If randomized to the BPCARE intervention, you would receive two structured intervention sessions within the first two months.
Compensation
Not stated in the trial record.
Follow-up
Participants are followed for six months after randomization.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07398391

Blood Pressure Care for Advancing Real-World Evidence (BPCARE)

Recruiting
NAAges 21+InterventionalTreatment
University of California, San Diego
~250 participants
Updated 2026-02-09 on ClinicalTrials.gov
What's tested:BPCARE Intervention

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Medication Adherence Assessed by Self-Report Questionnaire and Unannounced Pill Counts
Measured over From baseline/orientation until the end of the follow-up visit at 6 months post randomization

Conditions

Hypertension
High Blood Pressure

Explore related trials

Hypertension

Where it's being run

2 sites across 1 states
California2

Who to contact

Tala Al-Rousan, MD, MPH
[email protected]
619 356 3227
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Have a clinical diagnosis of hypertension determined at screening,
Be at least 21 years of age,
English as a second language,
Be able to provide written informed consent and participate in study procedures,
Have a last least one recorded automated clinic systolic BP reading of at least 130 mmHg within the past year OR at least one home SBP reading of ≥140 mmHg in the last year. AND/OR answer is in range of less than two months to "when was the last time you missed a dose of your hypertension medication?"
Will not move out of San Diego in the next 6 months, and
Have access to a mobile phone or computer with video telecommunication capacity (e.g. Zoom)

Exclusion

A cardiovascular event or hospitalization for unstable angina within last 3 months,
Symptomatic heart failure within the past 6 months or left ventricular ejection fraction \< 35%,
Individuals who are pregnant, planning on becoming pregnant within the next 7 months
Current participation in another clinical trial that includes taking medications that may change blood pressure, or
Major factors judged to be likely to significantly limit comprehension of or adherence to interventions including dementia, psychotic disorders, or affect ability to conduct pill counts
Any immediate family members participating in the trial.

What this trial measures

  • Medication Adherence Assessed by Self-Report Questionnaire and Unannounced Pill CountsFrom baseline/orientation until the end of the follow-up visit at 6 months post randomization

    Test the efficacy of BPCARE in improving antihypertensive medication adherence at 6 months post randomization (primary outcome; via self-report (Hill-Bone Compliance questionnaire), and unannounced pill counts (using video telecommunications)) compared to enhanced usual care. Hypotheses: BPCARE improves antihypertensive medication adherence H1a through H1b increased hypertension and medication adherence knowledge, H1c increased disease risk perceptions and therapeutic interest and motivation, H1d increased self-efficacy and behavioral skills, H1e reduced barriers, H1f long-term persistence (i.e., time to medication self-discontinuation at 6 months post randomization).